Skip to content
TrialScanner

NCT06555328

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

Phase 2TerminatedIFRXLead

Registry record

Lead sponsor
InflaRx GmbH
Conditions
Chronic Urticaria, Idiopathic; Hidradenitis; Hidradenitis Suppurativa
Primary completion
Jan 22, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06555328 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06555328: Evaluate Safety and Pharmacok... | TrialScanner